Role of antibody engineering in generation of derivatives starting from MOv19 MAb: 40 years of biological/therapeutic tools against folate receptor alfa
Author(s) -
Barbara Frigerio,
Matilde Montermini,
Silvana Canevari,
Mariangela Figini
Publication year - 2022
Publication title -
antibody therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.579
H-Index - 5
ISSN - 2516-4236
DOI - 10.1093/abt/tbac026
Subject(s) - monoclonal antibody , chimeric antigen receptor , antibody , conjugate , antigen , folate receptor , cancer research , receptor , antibody drug conjugate , immunotherapy , biology , immunology , medicine , cancer , immune system , cancer cell , mathematical analysis , mathematics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom